As Perlara approaches its 10 yr anniversary, Ethan Perlstein reflects on his entrepreneur's journey and vision for DTC biotech

blonca9
Dec 28, 2023
1 min read

Ethan Perlstein describes the past and present of his rare diseases-focused company Perlara, and makes the case for the "west coast," founder-led model of biotech he advocates for.

Recent Posts

See All

As federal funding for cancer research has been jeopardized at NIH and academia, Parker Institute for Cancer Immunotherapy is one private institution ready to step up and broaden its impact

Mount Sinai has embraced AI as a drug discovery tool by launching this month its new AI Small Molecule Drug Discovery Center - Professor Avner Schlessinger tells us why

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Soumit Roy and Justin Walsh share their take on biotech and comment on companies they cover

As Perlara approaches its 10 yr anniversary, Ethan Perlstein reflects on his entrepreneur's journey and vision for DTC biotech

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight